Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal
19 déc. 2024 08h00 HE
|
Bionano Genomics
Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal
Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility Across Blood Cancer Research and Cell & Gene Therapy
10 déc. 2024 08h00 HE
|
Bionano Genomics
Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility
Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress
13 nov. 2024 16h01 HE
|
Bionano Genomics
Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress
Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024
07 nov. 2024 16h01 HE
|
Bionano Genomics
Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024
Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
31 oct. 2024 16h30 HE
|
Bionano Genomics
SAN DIEGO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the closing of its previously announced registered direct offering priced at-the-marker under...
Bionano Adjourns Special Meeting of Stockholders to November 27, 2024
31 oct. 2024 08h10 HE
|
Bionano Genomics
SAN DIEGO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that it adjourned its reconvened Special Meeting of Stockholders originally held on October 2, 2024...
Bionano Announces $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
31 oct. 2024 08h00 HE
|
Bionano Genomics
SAN DIEGO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has entered into a definitive agreement with certain institutional investors for the...
Bionano Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma
24 oct. 2024 08h00 HE
|
Bionano Genomics
Publication shows that OGM can resolve translocation partners involving MYC in multiple myeloma (MM) more effectively than current methodsThe release of compelling data in MM underscores the potential...
Bionano Announces Preliminary 3Q 2024 Revenues and Cash
10 oct. 2024 08h00 HE
|
Bionano Genomics
SAN DIEGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced select preliminary results for the quarter ended September 30, 2024. The Company now expects...
Bionano Adjourns Special Meeting of Stockholders to October 30, 2024
03 oct. 2024 08h00 HE
|
Bionano Genomics
SAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that it has adjourned its Special Meeting of Stockholders held on October 2, 2024 (the “Special...